vimarsana.com
Home
Live Updates
EC grants CMA to Janssen's Talvey for multiple myeloma : vim
EC grants CMA to Janssen's Talvey for multiple myeloma : vim
EC grants CMA to Janssen's Talvey for multiple myeloma
The European Commission (EC) has granted conditional marketing authorisation (CMA) to the Janssen Pharmaceutical Companies of Johnson & Johnson’s Talvey.
Related Keywords
Peter Lebowitz ,
Drug Administration ,
Janssen Research Development Oncology ,
Development Oncology ,